Advertisement

Reactions Weekly

, Volume 1696, Issue 1, pp 3–3 | Cite as

Recent package insert revisions recommended by PMDA

News item

References

  1. 1.
    Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Tolvaptan. Internet Document : [2 pages], 20 Mar 2018. Available from: URL: http://www.pmda.go.jp/files/000223416.pdf
  2. 2.
    Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Anagliptin. Internet Document : [1 page], 20 Mar 2018. Available from: URL: http://www.pmda.go.jp/files/000223418.pdf
  3. 3.
    Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Anagliptin, linagliptin, and teneligliptin hydrobromide hydrate/canagliflozin hydrate. Internet Document : [2 pages], 20 Mar 2018. Available from: URL: http://www.pmda.go.jp/files/000223420.pdf
  4. 4.
    Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Selexipag and preparations containing clopidogrel sulfate. Internet Document : [3 pages], 20 Mar 2018. Available from: URL: http://www.pmda.go.jp/files/000223417.pdf

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations